Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    66.7%

    Based on 2 completed trials

    Completion Rate
    67%(2/3)
    Active Trials
    1(20%)
    Results Posted
    150%(3 trials)
    Terminated
    1(20%)

    Phase Distribution

    Not Applicable
    3
    60%
    Phase 2
    1
    20%
    Phase 2/3
    1
    20%

    Phase Distribution

    0

    Early Stage

    2

    Mid Stage

    0

    Late Stage

    Phase Distribution5 total trials
    Phase 2Efficacy & side effects
    1(20.0%)
    Phase 2/3Combined phases
    1(20.0%)
    N/ANon-phased studies
    3(60.0%)

    Highest Phase Reached

    Phase 2/3

    Trial Status & Enrollment

    Completion Rate

    66.7%

    2 of 3 finished

    Non-Completion Rate

    33.3%

    1 ended early

    Currently Active

    1

    trials recruiting

    Total Trials

    5

    all time

    Status Distribution
    Active(2)
    Completed(2)
    Terminated(1)

    Detailed Status

    Completed2
    Recruiting1
    Not yet recruiting1
    Terminated1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    5
    Active
    1
    Success Rate
    66.7%
    Most Advanced
    Phase 2/3

    Trials by Phase

    Phase 21 (20.0%)
    Phase 2/31 (20.0%)
    N/A3 (60.0%)

    Trials by Status

    recruiting120%
    not_yet_recruiting120%
    completed240%
    terminated120%

    Recent Activity

    1 active trials
    Showing 5 of 5
    not_yet_recruitingnot_applicable

    "Effects of EMST and Triflo on Voice Parameters and Vocal Fatigue"

    NCT07371351
    recruitingnot_applicable

    EMST in Patients Undergoing CRT for HNCA

    NCT03916809
    completedphase_2

    Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial

    NCT02927691
    terminatednot_applicable

    Expiratory Muscle Strength Training and Phonation Resistance Training Exercises For Elderly Patients With Vocal Fold Atrophy

    NCT03696576
    completedphase_2_3

    Expiratory Muscle Training for Persons With Neurodegenerative Disease

    NCT00856518

    Clinical Trials (5)

    Showing 5 of 5 trials
    NCT07371351Not Applicable

    "Effects of EMST and Triflo on Voice Parameters and Vocal Fatigue"

    Not Yet Recruiting
    NCT03916809Not Applicable

    EMST in Patients Undergoing CRT for HNCA

    Recruiting
    NCT02927691Phase 2

    Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial

    Completed
    NCT03696576Not Applicable

    Expiratory Muscle Strength Training and Phonation Resistance Training Exercises For Elderly Patients With Vocal Fold Atrophy

    Terminated
    NCT00856518Phase 2/3

    Expiratory Muscle Training for Persons With Neurodegenerative Disease

    Completed

    All 5 trials loaded

    Drug Details

    Intervention Type
    Varies by study
    Total Trials
    5